EBM Technologies Incorporated (8409) fair value: what the stock is really worth
As of Sep 24, 2026: fair value of EBM Technologies Incorporated TWD 6.68, price TWD 18.10, upside -63.1%, quality 59 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch EBM Technologies Incorporated for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
EBM Technologies Incorporated engages in the development and marketing of software and integrity solutions to the health sector in Taiwan and internationally.
Show more
EBM Technologies Incorporated engages in the development and marketing of software and integrity solutions to the health sector in Taiwan and internationally. The company offers Enterprise PACS (picture archiving and communication systems) solutions, including SoliPACS that unites various products of the radiology, mammography, and dental fields; SoliPACS Gateway, a DICOM gateway; SoliPACS Server, an interface between HIS and RIS patient data and PACS; SoliPACS Web Viewer, which enables radiologists and physicians to view, compare, utilize, and select DICOM-compliant images; SoliPACS Report, offers a tool for generating customized reports; and Advanced Server Archive, a PACS storage system. It also provides UDE (Ubiquitous Diagnostic Environment) App, which converts standard iPad Pro into a standalone DICOM server, viewer, display, and Al all in one; MobiPACS Server to store, process, and retrieve image files for mobile devices; MobiPACS App, an in mobile medical image viewing app; MobiPACS Web Viewer for viewing images from Internet-enabled end devices; MobiPACS Share, a cloud-based platform; and MobiPACS Multi, supports doctors to connect various iPads/iPad Pros for image display. In addition, the company offers Vital-Sign On-the-Go, a patient monitoring solution; Rad@, for viewing medical-grade images and diagnose; Digital Pathology Scanner, transforms physical slides to whole side images; AgileRIS App, an offline reporting solution; EPS Pi, a viewer ready DICOM device; and UniGate_i (UGI) App. Further, it provides Telemed, which interlinks medical facilities; Electronic Medical Record, a digital version of the paper-based individual medical record for patients' medical history; Personal Health Record, offers electronic access to the individual's medical history; and eHealth solutions for retrieving and reviewing patient images, vital sign data, and ECG waveforms. The company was founded in 1988 and is headquartered in Taipei, Taiwan.
Stock analysis
EBM Technologies Incorporated (8409) currently trades at 18.10 TWD, while our model-based Fair Value estimate is 6.68 TWD, implying the stock looks roughly 170.9% overvalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of 11.97 TWD per share, and 0 of the 13 models we run sit above the 18.10 TWD price.
Bear case: the Earnings-Based group reads lowest at 2.03 TWD, and 13 of the 13 models stay below the price. Evidence for this calculation is low.
Scenario range: 6.30 TWD (bear) to 7.02 TWD (bull), the price of 18.10 TWD sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 59/100 (solid quality), in the Healthcare sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
EBM Technologies Incorporated reported revenue of 253M TWD in FY2025 versus 195M TWD in FY2021, a compound +6.7%/yr. Reported net income was 7.8M TWD in FY2025.
Key figures
Market cap 579M TWD (≈ $18.2M) · P/E ratio 75.4 · P/S ratio 2.32 · EPS (TTM) 0.2400 TWD · Net margin 3.1% · Return on equity 10.3% · Return on assets (EBIT) −1.0% · Operating margin −8.5%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (low confidence).
What moves the price
The share trades about 29% below its 52-week high and 1% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −45% fair-value upside, at −63%, 8409 screens richer than that median.
Fair Value models
Bear 6.30 TWDFair Value 6.68 TWDBull 7.02 TWD
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (0.1762 TWD per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.19/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−9.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−13.0%
’21
’22
’23
’24
’25
What shareholders gained per year (last 3 years), in TWD (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 3 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip. Measured in TWD: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+24.9%
Earnings growth per share plus dividend.
Earnings per share, growth per year+24.9%
Dividend (yield on the price)0.0%
Profit margin 2021 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.−19% → 4%
2025 sits 154% above its own trend. The rate follows the median trend of the last 3 years, not that single year.
Compare EBM Technologies Incorporated with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Health Information Services · 134 stocks
Beats the industry median on 9/12 measures
Overall it ranks above its industry peers.
Valuation
Quality Score59 · Above median
Fair Value upside−64% · Below median
Profitability
Return on equity (TTM)10% · Top 25%
Return on assets5% · Top 25%
Net margin (TTM)11% · Top 25%
Operating margin (TTM)−9% · Below median
Growth and dividend
Revenue growth122% · Top 25%
Balance sheet
Debt / equity0.01× · Below median
Valuation Multiplesvs Health Information Services median · lower = cheaper
P/E (TTM)75.4× · Priciest 25%
P/B1.84× · Cheaper than median
P/S (TTM)2.08× · Cheaper than median
EV/EBITDA10.7× · Cheaper than median
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 3
FUTURE (revenue growth)100· sector 34
PAST (return on equity)41· sector 5
HEALTH (low debt)100· sector 98
DIVIDEND (yield)0· sector 48
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is EBM Technologies Incorporated (8409) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 6.68 TWD versus a price of 18.10 TWD, about −63% upside (overvalued).
What is the fair value of 8409?
Our model-based fair value for EBM Technologies Incorporated is 6.68 TWD (as of Sep 24, 2026), built from audited fundamentals. The current price: 18.10 TWD.
What is the quality score of 8409?
EBM Technologies Incorporated has a Quality Score of 59/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for EBM Technologies Incorporated (8409)?
Our model-based price target is the fair value of 6.68 TWD (as of Sep 24, 2026) from 13 valuation models. Cautious scenario 6.30 TWD, optimistic scenario 7.02 TWD. It is a calculation from audited fundamentals, not an analyst target.
What is the EBM Technologies Incorporated stock forecast for 2026?
Our models put fair value at 6.68 TWD, about −63% upside versus a price of 18.10 TWD (overvalued). Cautious scenario 6.30 TWD, optimistic scenario 7.02 TWD. The calculation is refreshed regularly with new filings.
What is the revenue of EBM Technologies Incorporated (8409)?
EBM Technologies Incorporated reported trailing-twelve-month revenue of about 281M TWD (latest available figure, as of Sep 24, 2026).
What is the intrinsic value of EBM Technologies Incorporated (8409)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For EBM Technologies Incorporated it is 6.68 TWD per share (as of Sep 24, 2026), against a price of 18.10 TWD. It is the blended result of 13 valuation models (cash flow, earnings, asset, dividend).
Is EBM Technologies Incorporated stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 8409 trades above its calculated fair value: price 18.10 TWD, fair value 6.68 TWD, a gap of about −63% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 8409?
No. The price is what the market pays today (18.10 TWD); the fair value is what the company's own numbers justify (6.68 TWD). For EBM Technologies Incorporated the two are 11.42 TWD per share apart. That gap is exactly why we show both numbers side by side.
How much is EBM Technologies Incorporated worth?
The market values EBM Technologies Incorporated at about 579M TWD (market capitalisation, as of Sep 24, 2026). Per share that is 18.10 TWD; our models calculate a fair value of 6.68 TWD per share.
What do the bullish and bearish scenarios say about 8409?
Our models span a range for EBM Technologies Incorporated: cautious scenario 6.30 TWD, base 6.68 TWD, optimistic 7.02 TWD per share (as of Sep 24, 2026, price 18.10 TWD). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 8409?
EBM Technologies Incorporated trades at a price-to-earnings ratio of 75.4 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 6.68 TWD is built from several models across several years. Other multiples: P/B 1.8, P/S 2.1, EV/EBITDA 10.7.
How solid is the balance sheet of EBM Technologies Incorporated (8409)?
Balance-sheet figures for EBM Technologies Incorporated (as of Sep 24, 2026): return on equity 10.3%, debt of 0.01 per unit of equity. They feed the Quality Score of 59/100, which measures business quality independently of the share price.
How far is 8409 from its 52-week high?
EBM Technologies Incorporated trades at 18.10 TWD, about 29% below its 52-week high of 25.35 TWD and 1% above the low of 17.90 TWD (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of 6.68 TWD is for.
Which stocks are comparable to EBM Technologies Incorporated?
From the same area (Healthcare) we also value Veeva Systems Inc, Pro Medicus Limited, BrightSpring Health Services, Inc, HealthEquity, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is EBM Technologies Incorporated stock attractive at the current price?
The data as of Sep 24, 2026: price 18.10 TWD, calculated fair value 6.68 TWD (−63%), Quality Score 59/100, from 13 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 8409 calculated?
We run EBM Technologies Incorporated through 13 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 6.68 TWD, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.2 % above its aggregate fair value. EBM Technologies Incorporated itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of EBM Technologies Incorporated (8409)?
The closing price on Sep 24, 2026 was 18.10 TWD. Our model-based fair value is 6.68 TWD, about −63% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with EBM Technologies Incorporated right now?
The price sits above even our optimistic bull case (7.02 TWD). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (59/100) and above fair value, neither a clear bargain nor a standout compounder. The models converge in a tight band (6.30 TWD to 7.02 TWD), unusually little disagreement for a valuation.
Key figures of EBM Technologies Incorporated
How large is the market capitalisation of EBM Technologies Incorporated (8409)?
The market capitalisation of EBM Technologies Incorporated is 579M TWD (≈ $18.2M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of EBM Technologies Incorporated (8409)?
The price-to-sales ratio of EBM Technologies Incorporated is 2.32 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of EBM Technologies Incorporated (8409)?
Earnings per share at EBM Technologies Incorporated are 0.2400 TWD (price ÷ EPS = P/E 75.4). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of EBM Technologies Incorporated (8409)?
The net margin of EBM Technologies Incorporated is 3.1% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of EBM Technologies Incorporated (8409)?
The return on equity (ROE) of EBM Technologies Incorporated is 10.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of EBM Technologies Incorporated (8409)?
On an EBIT basis the return on assets of EBM Technologies Incorporated is −1.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of EBM Technologies Incorporated (8409)?
The operating margin of EBM Technologies Incorporated is −8.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at EBM Technologies Incorporated (8409)?
Revenue at EBM Technologies Incorporated is growing +122% versus a year earlier (3y avg −13.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at EBM Technologies Incorporated (8409)?
Earnings per share at EBM Technologies Incorporated are growing −61.7% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does EBM Technologies Incorporated (8409) generate?
The free cash flow of EBM Technologies Incorporated is −75.3M TWD (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
Free · no account needed
Watch EBM Technologies Incorporated in the live analysis
One click puts EBM Technologies Incorporated on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
